Literature DB >> 30349577

Gerbode type defect after trans-septal puncture for ablation of left-sided accessory pathway.

Masoud Eslami1, Reza Mollazadeh2, Roya Sattarzadeh-Badkoubeh2.   

Abstract

BACKGROUND: Trans-septal puncture (TSP) is a safe and effective method to approach left atrium and ventricle. Nowadays, cardiac electrophysiologists perform this procedure routinely to treat left-sided arrhythmias. CASE REPORT: A 45-year-old man was referred to our center due to Wolff-Parkinson-White (WPW) syndrome. After trans-septal puncture, contrast injection into the sheath showed that it was in the left ventricle (LV) rather than left atrium. Trans-esophageal echocardiography confirmed left ventricle outflow tract to right atrial (RA) jet. Follow-up echocardiography showed that the tract was present up to 18 months, but considering that the patient was asymptomatic, endovascular or surgical closure was not done.
CONCLUSION: Our case with an 18-month follow-up period, highlights the conservative approach in asymptomatic patients with this complication.

Entities:  

Keywords:  Adverse Effects; Punctures; Radiofrequency Catheter Ablation

Year:  2018        PMID: 30349577      PMCID: PMC6191576          DOI: 10.22122/arya.v14i3.1671

Source DB:  PubMed          Journal:  ARYA Atheroscler        ISSN: 1735-3955


Introduction

Trans-septal puncture (TSP) is a safe and effective method to approach left atrium and ventricle. Nowadays, cardiac electrophysiologists perform this procedure routinely to treat left sided arrhythmias.1 Although pericardial effusion and tamponade are among the most serious complications of TSP,2 complications such as inadvertent puncture of aorta, and even aorto-right atrial shunt are rarely reported.3,4 Herein, we illustrate the occurrence of a rare TSP complication, and our approach to handle it.

Case Report

A 45-year-old man was referred to our center due to Wolff-Parkinson-White (WPW) syndrome for radiofrequency ablation. General physical examination was normal. Electrocardiography (ECG) showed pre-excitation in favor of left posterior accessory pathway (AP). Echocardiography was also normal. Guided by fluoroscopy, right atrium (RA), right ventricle, and coronary sinus catheters were introduced into the corresponding heart chambers. Basic electrophysiology study confirmed that AP was located in the posterior part of mitral valve ring; so we decided for TSP. This was the first time we used HeartSpan Steerable (Merit Medical Systems, South Jordan, UT, United States) sheath and the needle for TSP; in the previous TSP procedures, we used the AgilisTM sheath (Abbott, Saint Paul, MN, United States). Withdrawal of trans-septal sheath from superior vena cava into RA after 2 jumps usually places the introducer system in the fossa ovalis; but in this patient, this maneuver did not work despite several attempts. Finally, we could place the sheath into lower part of the interatrial septum, just above coronary sinus catheter in left anterior oblique projection. Jerky puncture with the needle was done and small amount of contrast injection showed that the needle has traversed the interatrial septum. So, we advanced the steerable sheath over the needle to the left side, and then the needle was withdrawn. However, to our surprise, contrast injection into the side branch of the sheath showed that it was in the left ventricle (LV) rather than the left atrium (Figure 1-A). We advanced the 0.032” guidewire through the sheath to LV, and retracted the sheath to RA. Continuous arterial blood pressure monitoring did not show hemodynamic compromise, nor did echocardiography show pericardial effusion; so we decided to perform radiofrequency ablation of AP via the retrograde trans-aortic approach that was successful (Figure 1-B).
Figure 1

A: Contrast injection after trans-septal puncture through the sheath shows that LV is penetrated. B: RAO and LAO projections at the site of successful ablation (posterior of mitral valve ring). C: TTE shows abnormal flow in the RA. D: TEE shows LV outflow tract to RA flow. Abl: Ablation catheter; CS: Coronary sinus; LA: Left atrium; LAO: Left anterior oblique; LV: Left ventricle; RA: Right atrium; RAO: Right anterior oblique, RV: Right ventricle; TEE: Trans-esophageal echocardiography; TTE: Transthoracic and echocardiography

We transferred the patient to coronary care unit (CCU) for better hemodynamic monitoring. On the next day, transthoracic and trans-esophageal echocardiography showed LV outflow tract to RA jet (Figure 1-C and 1-D respectively). The patient was discharged uneventfully. Follow-up echocardiography showed that the tract was present for up to 18 months without any evidence of cardiac enlargement (Figure 2). Since the patient was asymptomatic, endovascular or surgical closure was not attempted.
Figure 2

Persistent LV to RA fistula 18 months later LA: Left atrium; LV: Left ventricle; RA: Right atrium; LVOT: Left ventricular outflow tract

Discussion

Our case is unique in two aspects; first, a very rare complication of TSP, RA to LV penetration (Gerbode) and fistula formation, but more interestingly is the second, persistence of this fistula over 18 months of medical follow-up without any intervention usually needed in similar symptomatic cases.5 Can et al. presented a case with Gerbode type defect after ablation of atrioventricular node from the LV to RA. They stated that radiofrequency ablation was uncomplicated and at 5-month routine medical follow up, they found a LV to RA fistula. At 14-month follow-up, the size of defect did not show any progression; so they did not perform any intervention.6 The most similar article to ours was presented by Chavarria and Goldbarg.7 They presented left ventricular penetration detected during trans-septal puncture of interatrial septum for ablation of left posterior accessory pathway. After discovering the complication in the catheterization laboratory, they postponed the definite procedure to another day. They addressed that the patient was asymptomatic during several weeks follow-up. In our case, we speculated that the superior part of membranous septum was punctured inadvertently, and a Gerbode-like defect with flow from the LV to the RA was made. It is predictable that if intracardiac echocardiography was available in our electrophysiology laboratory, this complication could be avoided. Our case, with 18-month follow-up, highlights the conservative approach in asymptomatic patients with this complication.
  6 in total

1.  Images in cardiovascular medicine. Gerbode-type defect induced by catheter ablation of the atrioventricular node.

Authors:  Ilknur Can; Kristopher Krueger; Yellaprada Chandrashekar; Jian-Ming Li; Richard Dykoski; Venkatakrishna N Tholakanahalli
Journal:  Circulation       Date:  2009-06-09       Impact factor: 29.690

2.  Aorto-right atrial fistula: a rare complication of trans-septal puncture and catheter ablation for atrial fibrillation.

Authors:  Michael Y C Tsang; Donald J Hagler; Joseph A Dearani; Charanjit S Rihal; Nandan S Anavekar
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2013-08-07       Impact factor: 6.875

3.  A rare complication from transseptal puncture-persistent aorto-right atrial shunt and puncture of noncoronary cusp of aortic valve.

Authors:  Simon Claridge; Stam Kapetanakis; Jas Gill; Christopher Aldo Rinaldi; Matthew Wright
Journal:  Heart Rhythm       Date:  2011-08-09       Impact factor: 6.343

4.  Complications of transseptal catheterization for different cardiac procedures.

Authors:  George D Katritsis; George C M Siontis; Eleftherios Giazitzoglou; Nikolaos Fragakis; Demosthenes G Katritsis
Journal:  Int J Cardiol       Date:  2013-08-14       Impact factor: 4.164

5.  Trans-septal catheterization for radiofrequency catheter ablation of cardiac arrhythmias. Results and safety of a simplified method.

Authors:  R De Ponti; M Zardini; C Storti; M Longobardi; J A Salerno-Uriarte
Journal:  Eur Heart J       Date:  1998-06       Impact factor: 29.983

6.  Left ventricle penetration-A rare complication of transseptal puncture and catheter ablation for supraventricular tachycardia.

Authors:  Nelson Chavarria; Seth Goldbarg
Journal:  HeartRhythm Case Rep       Date:  2015-04-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.